Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

223
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
223
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

245
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
245
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

6
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
6

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological Approaches and Innovative Strategies for Individualized Patient Care.

Recent patents on biotechnology·2025
Same author

Diagnostic Accuracy of Furosemide Stress Test and Cystatin-C for Predicting Acute Kidney Injury Progression in Children: A Prospective Cohort Study.

Indian journal of pediatrics·2025
Same author

An Outline on Benzimidazole Containing Marketed Drugs with Proton Pump Inhibitor and H<sub>1</sub> Receptor Antagonist Activities.

Mini reviews in medicinal chemistry·2025
Same author

Association of Specific Dietary Fatty Acids with Asthma in Urban School Children and Adolescents: Inferences from a Cross-Sectional Multicentric Study From India.

Indian pediatrics·2025
Same author

Multi-locus genome wide association study uncovers genetics of fresh seed dormancy in groundnut.

BMC plant biology·2024
Same author

Relationship between perceived social support, mental adjustment to cancer, and depression among patients with breast cancer.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2024

Related Experiment Video

Updated: Oct 8, 2025

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K

Bariatric Surgery in NAFLD.

Mahak Chauhan1, Kuldeep Singh1, Paul J Thuluvath2,3

  • 1Institute of Digestive Health and Liver Diseases, Mercy Medical Center, Baltimore, MD, USA.

Digestive Diseases and Sciences
|January 4, 2022
PubMed
Summary
This summary is machine-generated.

Bariatric surgery may improve liver health in nonalcoholic steatohepatitis (NASH) patients with fibrosis or cirrhosis. This review explores its benefits beyond weight loss for NASH management.

Keywords:
CirrhosisCost analysisImprovement of NAFLDLiver transplantMechanismsRisks of surgery

More Related Videos

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.2K
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

728

Related Experiment Videos

Last Updated: Oct 8, 2025

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.2K
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

728

Area of Science:

  • Hepatology
  • Gastroenterology
  • Metabolic Surgery

Background:

  • Nonalcoholic steatohepatitis (NASH) with fibrosis/cirrhosis lacks approved drug treatments.
  • Lifestyle modifications for weight loss are often insufficient for NASH patients.
  • Bariatric surgery is an alternative for patients failing lifestyle changes.

Purpose of the Study:

  • To review the role of bariatric surgery in managing NASH-related liver disease.
  • To explore potential mechanisms behind bariatric surgery's benefits in NASH.
  • To critically appraise current knowledge on bariatric surgery for NASH.

Main Methods:

  • Literature review of studies on bariatric surgery and NASH.
  • Analysis of evidence for liver histology improvement.
  • Assessment of associated metabolic and cardiovascular benefits.

Main Results:

  • Bariatric surgery improves liver histology, including NASH-related fibrosis.
  • Significant improvements in type 2 diabetes, dyslipidemia, and hypertension observed.
  • Reduced cardiovascular morbidity and mortality are potential benefits.

Conclusions:

  • Bariatric surgery offers significant benefits for NASH patients with fibrosis/cirrhosis.
  • Further research is needed to establish specific guidelines for NASH management.
  • Surgery addresses multiple comorbidities associated with NASH.